Literature DB >> 9789970

Concordant message of different inflammatory markers in patients with rheumatoid arthritis.

N G Arvidsson1, B Gudbjörnsson, R Hällgren, A Larsson.   

Abstract

The acute phase reaction is an unspecific response to inflammatory stimuli characterized by alterations in the concentration of several plasma proteins. It is of great clinical value to monitor the inflammatory state in patients with rheumatoid arthritis. The erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are the assays most widely used to measure the acute phase response, but there are also several other inflammatory markers (e.g., fibrinogen, haptoglobin, alpha 1-acid glycoprotein, alpha 1-antitrypsin, interleukins (IL), serum amyloid component A (SAA)). We have studied the interrelationships between several of these markers (ESR, Haptoglobin, Fibrinogen, CRP, SAA and IL-6) in rheumatoid arthritis patients. There was a good correlation between all acute phase markers in serum (p < .01). We found especially strong correlations between S-CRP and SAA (p < .000001) and between ESR and P-fibrinogen (p = .000004). The strong correlation indicates that P-fibrinogen could be used instead of ESR in monitoring rheumatoid arthritis patients. This would increase the specificity of the examination as ESR may be influenced by several factors other than the inflammatory response. There were no significant correlations between acute phase markers in serum or plasma and clinical index.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9789970     DOI: 10.3109/03009739809178943

Source DB:  PubMed          Journal:  Ups J Med Sci        ISSN: 0300-9734            Impact factor:   2.384


  5 in total

1.  Use of two-dimensional gel electrophoresis to measure changes in synovial fluid proteins from patients with rheumatoid arthritis treated with antibody to CD4.

Authors:  M A Smith; S K Bains; J C Betts; E H Choy; E D Zanders
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

2.  Levels of interleukin-1 beta can predict response to tocilizumab therapy in rheumatoid arthritis: the PETITE (predictors of effectiveness of tocilizumab therapy) study.

Authors:  Tadashi Okano; Kentaro Inui; Masahiro Tada; Yuko Sugioka; Kenji Mamoto; Shigeyuki Wakitani; Tatsuya Koike; Hiroaki Nakamura
Journal:  Rheumatol Int       Date:  2015-10-05       Impact factor: 2.631

Review 3.  Progress in the use of biochemical and biological markers for evaluation of rheumatoid arthritis.

Authors:  R M Nakamura
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

4.  Distinct expression of chemokine-like factor 1 in synovium of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.

Authors:  Ke Tao; Xu Tang; Bin Wang; Ru-Jun Li; Bao-Qing Zhang; Jian-Hao Lin; Hu Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-02-03

Review 5.  Understanding emerging treatment paradigms in rheumatoid arthritis.

Authors:  Ferdinand C Breedveld; Bernard Combe
Journal:  Arthritis Res Ther       Date:  2011-05-25       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.